PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12598410-0	2003	Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).	Dipeptides	25-34	vasoactive intestinal peptide	Homo sapiens	65-68	
12598410-3	2003	The ability of the anti-absorptive enteric neuropeptide VIP (vasoactive intestinal peptide) to modulate dipeptide uptake was determined using human intestinal (Caco-2) epithelial cell monolayers.	Dipeptides	104-113	vasoactive intestinal peptide	Homo sapiens	56-59	
12598410-3	2003	The ability of the anti-absorptive enteric neuropeptide VIP (vasoactive intestinal peptide) to modulate dipeptide uptake was determined using human intestinal (Caco-2) epithelial cell monolayers.	Dipeptides	104-113	vasoactive intestinal peptide	Homo sapiens	61-90	
12598410-12	2003	Experiments with BCECF [2",7"-bis(2-carboxyethyl)-5(6)-carboxyfluorescein]-loaded Caco-2 cells demonstrate that VIP reduces the NHE3-dependent recovery of intracellular pH (pH(i)) after dipeptide-induced acidification.	Dipeptides	186-195	vasoactive intestinal peptide	Homo sapiens	112-115	
12598410-15	2003	VIP has no effect on Gly-Sar uptake in the presence of S1611 suggesting that VIP and S1611 both modulate dipeptide uptake via the same mechanism.	Dipeptides	105-114	vasoactive intestinal peptide	Homo sapiens	77-80	
12598410-17	2003	These observations demonstrate that VIP (and PACAP) modulate activity of the H(+)/dipeptide transporter hPepT1 in a Na(+)-dependent manner consistent with the modulation being indirect through inhibition of NHE3.	Dipeptides	82-91	vasoactive intestinal peptide	Homo sapiens	36-39